A 20-cent-per-share payment from Bath & Body Works is due Dec. 4.

Bath & Body Works (BBWI) declared a quarterly dividend of $0.20 per share, payable on Dec. 4. The company operates 1,900+ U.S. and Canada stores, 550+ international locations, and sells online.

Original reporting
Published Nov 6, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 1:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BBWI
Neutral
high confidence
Mentioned
$BBWI
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BBWINeutralLow
01

Why it matters

The dividend adds a modest yield, likely attracting income investors but unlikely to drive significant price movement.

02

Market read

A routine dividend announcement with limited trading impact.

03

What to watch

Potential tax considerations for dividend-receiving investors and upcoming earnings could dominate price action.

Relevance 5/10Novelty 4/10Timing: announcement today

Background

Bath & Body Works is a leading personal care and home fragrance retailer with over 1,900 U.S. stores and international locations.

Company-level read

Ticker impact

$BBWINeutralHigh confidence
Context

Bath & Body Works announced a regular quarterly dividend of $0.20 per share payable on Dec. 4.

Expected impact

slight upward pressure as the market incorporates the dividend payment.

Evidence & confidence

Dividends typically attract income-focused investors; the amount is modest, so impact is limited but positive.

Market effects

May slightly boost the consumer discretionary sector's dividend yield appeal.

Limited to U.S. investors; no broader regional effect.

Minimal global impact beyond BBWI shareholders.

Counterpoint

The dividend is small and may not offset broader market weakness, so price could stay flat.

Key entities

  • Bath & Body Works, Inc.

    Issuer of the dividend.

Related articles

$BBYMed

Sportsman's Warehouse (NASDAQ:SPWH): Strongest Q2 Results from the Specialty Retail Group

Best Buy (BBY) reported Q2 revenue of $9.78B, up 3.6% YoY, beating estimates. Its stock rose 3.7% post-earnings. Dick's (DKS) reported $5.59B revenue, up 53.2% YoY, missing estimates. Its stock fell 24.7%. Sally Beauty (SBH) reported flat revenue of $935.5M, meeting expectations. Bath & Body Works (BBWI) reported $1.51B revenue, down 2.3% YoY, beating estimates. Its stock rose 4.8%.

$BBWIMed

How Investors May Respond To Bath & Body Works (BBWI) Stronger EPS Guidance Amid Softer Sales And Buybacks

Bath & Body Works (BBWI) reported Q2 2026 net income of $118M on $1.51B sales, completed a $382.93M share buyback, and updated guidance for a 4% to 2.5% decline in full-year sales but higher EPS. The company launched the Reserve Collection, focusing on product innovation. Analysts debate the stock's value, with projections ranging from $7.2B to $7.6B revenue by 2029.

$BBWIMedAI 8/10

Bath & Body Works, Inc. Q2 2027 Earnings Call Summary

Bath & Body Works reported Q2 2027 sales beat due to digital growth and expanded distribution. The company is shifting focus to enduring franchises and exiting the Home Care category. Digital sales improved, and management reinvested $35M in marketing. Guidance was narrowed, assuming macro pressures persist. Q2 results included an $80M tariff refund benefit. Management discussed sustainability of digital growth, store traffic strategies, and partnerships with Amazon and Ulta.

$BBWIMedAI 8/10

Bath & Body Works Q2 Earnings Call Highlights

Bath & Body Works reported Q2 sales of $1.1 billion, down 5.4% YoY, with direct-channel sales up 3% and international revenue up 24.9%. The company's digital business grew, and new product launches exceeded expectations. Bath & Body Works plans to exit its home-care category and expand distribution with Amazon and Ulta. It narrowed its full-year sales outlook to a decline of 2.5% to 4% and raised adjusted EPS guidance to $2.60 to $2.80.